Vaping Cancer Risk Evidence
Key Questions
What evidence links vaping to cancer risks?
Vaping is tied to mouth and lung cancers through DNA damage, inflammation, and mouse tumors (22.5% incidence), with a 20-40 year latency period. Australian UNSW research on March 30, 2026, identified carcinogens in vapes. A comprehensive review confirms these risks.
How do e-cigarettes compare to NRT for quitting?
Oxford studies show e-cigarettes outperform nicotine replacement therapy (NRT) for quitting smoking but still carry risks. ENDS reviews flag cardiovascular and respiratory issues across 69 systematic reviews. This pressures reduced-risk product claims for NJOY and on! versus HTP or snus.
What other health concerns are associated with vaping?
Toddler exposures to vapes surged 243%, now the top nicotine threat for children under five, involving inhalation. Vaping shows risks in low- and middle-income countries with NVP surges. Australian market developments highlight ongoing tobacco product innovations amid these concerns.
Vaping ties to mouth/lung cancers via DNA damage/inflammation/mouse tumors (22.5%), 20-40yr latency; Aus UNSW (3/30/26) carcinogens; Oxford e-cigs >NRT quitting but risks; ENDS review flags CV/respiratory (69 sys reviews). Pressures RRP claims for NJOY/on! vs HTP/snus; toddler exposures +243%, NVPs LMICs surge.